In Vitro Pharmacokinetic Optimizations of AM2-S31N Channel Blockers Led to the Discovery of Slow-Binding Inhibitors with Potent Antiviral Activity against Drug-Resistant Influenza A Viruses.

Publication

Citation: Wang Y, Hu Y, Xu S, Zhang Y, Musharrafieh R, Hau RK, Ma C, Wang J.: In Vitro Pharmacokinetic Optimizations of AM2-S31N Channel Blockers Led to the Discovery of Slow-Binding Inhibitors with Potent Antiviral Activity against Drug-Resistant Influenza A Viruses. J Med Chem, Volume 61 (3), 2018
Authors: Hau RK, Hu Y, Ma C, Musharrafieh R, Wang J., Wang Y, Xu S, Zhang Y
Journal: J Med Chem
Year: 2018
DOI: 10.1021/acs.jmedchem.7b01536
PubMed: 29341607
Machine-readable: REST API RDF